Author

Kyle Kasprzak

University of Vermont

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anne K SnyderiD· 1 shared Anne Kelsen· 1 shared Binod NepaliD· 1 shared Bruno Martorelli Di GenovaiD· 1 shared Christopher D. HustoniD· 1 shared David M. WarshawiD· 1 shared Eddie WehriiD· 1 shared Emmett A. Dews· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Anne K SnyderORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasites

Anne K Snyder, Filomena Tedesco, Anne Kelsen, Eddie Wehri, Binod Nepal, Jose Teixeira, Emmett A. Dews, Sachie Kanatani, Kyle Kasprzak, Jonathan Oliva, Kaesi A. Morelli, Samantha Beck Previs, Bruno Martorelli Di Genova, Francis M. Sverdrup, Martin J. Boulanger, , Gary E. Ward

This paper identifies UCB-9721 as a potent inhibitor of T. gondii MyoA, showing greater potency than KNX-002 and inhibiting related apicomplexan parasites.

bioRxiv · Jun 19, 2026 · PreprintMicrobiology